A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Clinical trial NCT05837897 · RECRUITING

Trial details

NCT number: NCT05837897
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2023-06-16
Primary completion: 2030-03-08
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.